Liu Z, Sun Y K, Xi Y P, Maffei A, Reed E, Harris P, Suciu-Foca N
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York 10032.
J Exp Med. 1993 Jun 1;177(6):1643-50. doi: 10.1084/jem.177.6.1643.
T cells from an HLA-DR11/DR12 responder were stimulated in mixed lymphocyte culture with cells carrying the DR1 antigen. After priming, T cells proliferated in response to both DR1-positive-stimulating cells and a peptide derived from a polymorphic region of the HLA-DR beta 1*0101 chain presented by responder's antigen-presenting cells (APC). The dominant epitope recognized by the primed T cells corresponded to residue 21-42 and was presented by the responder's HLA-DR12 antigen. The DR1 peptide-reactive T cells express T cell receptor V beta 3. The results demonstrate that allopeptides derived from the processing and presentation of donor major histocompatibility complex molecules by host-derived APC trigger alloreactivity. The frequency of T cells engaged in the indirect pathway of allorecognition is about 100-fold lower than that of T cells participating in the direct recognition of native HLA-DR antigen. However, indirect allorecognition may play an important role in chronic allograft rejection, a phenomenon that is mediated by the activation of T helper cells and of alloantibody-producing B cells.
来自HLA - DR11/DR12应答者的T细胞在混合淋巴细胞培养中与携带DR1抗原的细胞一起受到刺激。致敏后,T细胞对DR1阳性刺激细胞以及由应答者的抗原呈递细胞(APC)呈递的源自HLA - DRβ1*0101链多态性区域的肽产生增殖反应。致敏T细胞识别的主要表位对应于21 - 42位氨基酸残基,由应答者的HLA - DR12抗原呈递。DR1肽反应性T细胞表达T细胞受体Vβ3。结果表明,宿主来源的APC对供体主要组织相容性复合体分子进行加工和呈递所产生的同种异体肽引发了同种异体反应性。参与间接同种异体识别途径的T细胞频率比参与直接识别天然HLA - DR抗原的T细胞频率低约100倍。然而,间接同种异体识别可能在慢性同种异体移植排斥反应中起重要作用,这一现象由辅助性T细胞和产生同种异体抗体的B细胞的激活介导。